Veninga A - Search Results

1

Maintenance of tumoricidal activity and susceptibility to reactivation of subpopulations of rat liver macrophages.

Daemen T, Veninga A, Regts J, Scherphof GL. Daemen T, et al. Among authors: veninga a. J Immunother (1991). 1991 Jun;10(3):200-6. doi: 10.1097/00002371-199106000-00006. J Immunother (1991). 1991. PMID: 1868044

2

Therapy of murine liver metastases by administration of MDP encapsulated in liposomes.

Daemen T, Dontje BH, Veninga A, Scherphof GL, Oosterhuis WL. Daemen T, et al. Among authors: veninga a. Sel Cancer Ther. 1990 Summer;6(2):63-71. doi: 10.1089/sct.1990.6.63. Sel Cancer Ther. 1990. PMID: 2367753

3

Endocytic and tumoricidal heterogeneity of rat liver macrophage populations.

Daemen T, Veninga A, Roerdink FH, Scherphof GL. Daemen T, et al. Among authors: veninga a. Sel Cancer Ther. 1989 Winter;5(4):157-67. doi: 10.1089/sct.1989.5.157. Sel Cancer Ther. 1989. PMID: 2623381

4

Conditions controlling tumor cytotoxicity of rat liver macrophages mediated by liposomal muramyl dipeptide.

Daemen T, Veninga A, Roerdink FH, Scherphof GL. Daemen T, et al. Among authors: veninga a. Biochim Biophys Acta. 1989 Apr 25;991(1):145-51. doi: 10.1016/0304-4165(89)90040-8. Biochim Biophys Acta. 1989. PMID: 2713416

5

Differential effects of liposome-incorporation on liver macrophage activating potencies of rough lipopolysaccharide, lipid A, and muramyl dipeptide. Differences in susceptibility to lysosomal enzymes.

Daemen T, Veninga A, Dijkstra J, Scherphof G. Daemen T, et al. Among authors: veninga a. J Immunol. 1989 Apr 1;142(7):2469-74. J Immunol. 1989. PMID: 2926140

6

In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide.

Daemen T, Veninga A, Roerdink FH, Scherphof GL. Daemen T, et al. Among authors: veninga a. Cancer Res. 1986 Sep;46(9):4330-5. Cancer Res. 1986. PMID: 3731091

7

Susceptibility for infection-related glomerulopathy depends on non-MHC genes.

van Velthuysen ML, Veninga A, Bruijn JA, de Heer E, Fleuren GJ. van Velthuysen ML, et al. Among authors: veninga a. Kidney Int. 1993 Mar;43(3):623-9. doi: 10.1038/ki.1993.91. Kidney Int. 1993. PMID: 8455361 Free article.

8

Antigenic specificities of glomerular-bound autoantibodies in membranous glomerulopathy induced by mercuric chloride.

Aten J, Veninga A, Bruijn JA, Prins FA, de Heer E, Weening JJ. Aten J, et al. Among authors: veninga a. Clin Immunol Immunopathol. 1992 Apr;63(1):89-102. doi: 10.1016/0090-1229(92)90098-9. Clin Immunol Immunopathol. 1992. PMID: 1591888

9

Susceptibility to the induction of either autoimmunity or immunosuppression by mercuric chloride is related to the major histocompatibility complex class II haplotype.

Aten J, Veninga A, De Heer E, Rozing J, Nieuwenhuis P, Hoedemaeker PJ, Weening JJ. Aten J, et al. Among authors: veninga a. Eur J Immunol. 1991 Mar;21(3):611-6. doi: 10.1002/eji.1830210312. Eur J Immunol. 1991. PMID: 2009908

10

Qualitative alterations in laminin expression in experimental lupus nephritis.

Kootstra CJ, Bergijk EC, Veninga A, Prins FA, de Heer E, Abrahamson DR, Bruijn JA. Kootstra CJ, et al. Among authors: veninga a. Am J Pathol. 1995 Aug;147(2):476-88. Am J Pathol. 1995. PMID: 7543736 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters